Novartis | NOVN - Actif À Court Terme

Prix De L'Action
113.70
Variation Quotidienne
-2.58 -2.22%
Mensuellement
-4.95%
Annuel
22.87%
Q2 Prévisions
111.47




Actif À Court Terme Changement Date
AbbVie USD 29.06B 523M 2025-12
Alcon AG USD 6.45B 116M 2025-12
Almirall EUR 713.98M 69K 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Autolus Therapeutics Ltd USD 435.92M 78.66M 2025-12
Bayer EUR 32.91B 30M 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Fresenius EUR 12.06B 1.18B 2025-09
Fresenius Medical Care EUR 7.9B 74M 2025-12
Galapagos EUR 3.08B 82.56M 2025-12
Genmab DKK 2.88B 1.59B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
GRIFOLS EUR 5.07B 274.77M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
J&J USD 59.17B 3.55B 2026-03
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.23B 354M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Orion EUR 1.41B 66.8M 2026-03
Pfizer USD 46.92B 3.22B 2025-09
Philips EUR 9.93B 654M 2025-12
Recordati EUR 1.71B 144.32M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
UCB EUR 6.05B 733M 2025-12